Redox active iron accumulation in aceruloplasminemia

Neuropathology

Volumn 28, Issue 5, 2008, Pages 466-471

  Gonzalez Cuyar, Luis F ^b   Perry, George ^c,d   Miyajima, Hiroaki ^e   Atwood, Craig S ^c,f   Riveros Angel, Marcela ^b   Lyons, Patrick F ^c,g   Siedlak, Sandra L ^c   Smith, Mark A ^c   Castellani, Rudy J ^a,b  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d University of San Antonio   (United States)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aceruloplasminemia; Ceruloplasmin; Iron; Oxidative stress

Indexed keywords

IRON;

ACERULOPLASMINEMIA; ADULT; AGED; ARTICLE; ASTROCYTE; AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; BRAIN DEGENERATION; BRAIN DISEASE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENETIC PROCEDURES; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; NERVE CELL LESION; NEUROPATHOLOGY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 49749087615     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2008.00901.x     Document Type: Article

References (39)

1. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998 67 : 972S 77S.
2. Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003 23 : 345 350.
3. Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev 2005 49 : 633 640.
4. Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci 2004 1012 : 299 305.
5. Miyajima H, Takahashi Y, Kono S et al. Glucose and oxygen hypometabolism in aceruloplasminemia brains. Intern Med 2002 41 : 186 190.
6. Oide T, Yoshida K, Kaneko K, Ohta M, Arima K. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. Neuropathol Appl Neurobiol 2006 32 : 170 176.
7. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GP. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. QJM 1994 87 : 663 670.
8. Morita H, Inoue A, Yanagisawa N. [A case of ceruloplasmin deficiency which showed dementia, ataxia and iron deposition in the brain]. Rinsho Shinkeigaku 1992 32 : 483 487.
9. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995 92 : 2539 2543.
10. Miyajima H, Takahashi Y, Serizawa M, Kaneko E, Gitlin JD. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic Biol Med 1996 20 : 757 760.
11. Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 2002 36 : 303 306.
12. Castellani RJ, Honda K, Zhu X et al. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res Rev 2004 3 : 319 326.
13. Castellani RJ, Siedlak SL, Perry G, Smith MA. Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol (Berl) 2000 100 : 111 114.
14. Petersen RB, Siedlak SL, Lee HG et al. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol (Berl) 2005 110 : 232 238.
15. Perry G, Lipphardt S, Mulvihill P et al. Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet 1988 2 : 746.
16. Smith MA, Hirai K, Hsiao K et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998 70 : 2212 2215.
17. Sternberger LA, Sternberger NH. The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem 1986 34 : 599 605.
18. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000 74 : 270 279.
19. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997 94 : 9866 9868.
20. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987 37 : 761 767.
21. Hellman NE, Kono S, Miyajima H, Gitlin JD. Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem 2002 277 : 1375 1380.
22. Royle NJ, Irwin DM, Koschinsky ML, MacGillivray RT, Hamerton JL. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat Cell Mol Genet 1987 13 : 285 292.
23. Daimon M, Yamatani K, Igarashi M et al. Fine structure of the human ceruloplasmin gene. Biochem Biophys Res Commun 1995 208 : 1028 1035.
24. Koschinsky ML, Funk WD, van Oost BA, MacGillivray RT. Complete cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci USA 1986 83 : 5086 5090.
25. Bosio S, De Gobbi M, Roetto A et al. Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood 2002 100 : 2246 2248.
26. Hahn P, Qian Y, Dentchev T et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 2004 101 : 13850 13855.
27. Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med 2003 42 : 599 604.
28. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 1996 5 : 81 84.
29. Patel BN, David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 1997 272 : 20185 20190.
30. Levin LA, Geszvain KM. Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest Ophthalmol Vis Sci 1998 39 : 157 163.
31. Sato M, Gitlin JD. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 1991 266 : 5128 5134.
32. Gitlin JD, Schroeder JJ, Lee-Ambrose LM, Cousins RJ. Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem J 1992 282 (3 835 839.
33. Donovan A, Brownlie A, Zhou Y et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000 403 : 776 781.
34. Jeong SY, David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 2003 278 : 27144 27148.
35. Messerschmidt A, Huber R. The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin. Modelling and structural relationships. Eur J Biochem 1990 187 : 341 352.
36. Osaki S, Johnson DA. Mobilization of liver iron by ferroxidase (ceruloplasmin). J Biol Chem 1969 244 : 5757 5758.
37. Heikkila RE, Winston B, Cohen G. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochem Pharmacol 1976 25 : 1085 1092.
38. Miyajima H, Kono S, Takahashi Y, Sugimoto M. Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains. Blood Cells Mol Dis 2002 29 : 433 438.
39. Castellani RJ, Smith MA, Nunomura A, Harris PL, Perry G. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radic Biol Med 1999 26 : 1508 1512.